Margaret Tooth Sells 491 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 491 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $31.84, for a total transaction of $15,633.44. Following the completion of the sale, the chief executive officer directly owned 186,952 shares in the company, valued at $5,952,551.68. This represents a 0.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90.

Trupanion Price Performance

Shares of Trupanion stock traded down $1.65 on Wednesday, hitting $30.19. 678,107 shares of the company traded hands, compared to its average volume of 439,698. The firm’s 50-day simple moving average is $26.63 and its 200 day simple moving average is $26.02. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The company has a market cap of $1.32 billion, a P/E ratio of 56.96, a P/E/G ratio of 2.15 and a beta of 1.39. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. The company had revenue of $392.93 million during the quarter, compared to analyst estimates of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 earnings per share. Analysts expect that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Trupanion

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Royal Bank of Canada raised its holdings in Trupanion by 60.6% in the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after purchasing an additional 11,233 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Trupanion by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock worth $731,000 after buying an additional 858 shares during the period. Millennium Management LLC increased its stake in shares of Trupanion by 73.5% in the 1st quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock worth $9,987,000 after acquiring an additional 113,490 shares in the last quarter. Invesco Ltd. increased its stake in shares of Trupanion by 35.1% in the 2nd quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after acquiring an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC purchased a new position in Trupanion during the 2nd quarter valued at about $249,000.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on TRUP. Atlantic Securities set a $42.00 price objective on Trupanion in a report on Wednesday, July 15th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday. Weiss Ratings upgraded shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, August 12th. Stifel Nicolaus lifted their price target on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Finally, Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $45.00 to $32.00 in a research note on Wednesday. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $39.20.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.